Zobrazeno 1 - 10
of 88
pro vyhledávání: '"J. Pedro Simas"'
Autor:
Kiran Iqbal Masood, Shama Qaiser, Syed Hani Abidi, Erum Khan, Syed Faisal Mahmood, Areeba Hussain, Zara Ghous, Khekahsan Imtiaz, Natasha Ali, Muhammad Hasan, Haris Ali Memon, Maliha Yameen, Shiza Ali, Sadaf Baloch, Gulzar Lakhani, Paula M. Alves, Najeeha Talat Iqbal, Kumail Ahmed, Junaid Iqbal, Zulfiqar A. Bhutta, Rabia Hussain, Martin Rottenberg, J. Pedro Simas, Marc Veldhoen, Kulsoom Ghias, Zahra Hasan
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Protection against SARS-CoV-2 is mediated by humoral and T cell responses. Pakistan faced relatively low morbidity and mortality from COVID-19 through the pandemic. To examine the role of prior immunity in the population, we studi
Externí odkaz:
https://doaj.org/article/daab1b9127084bd1ae6c4561d555d5e2
Autor:
Shijun Li, Mengbo Wang, Nicholas Van Sciver, Agnieszka Szymula, Vinayak Sadasivam Tumuluri, Athira George, Akshaya Ramachandran, Komal Raina, Catarina N. Costa, Bo Zhao, Majid Kazemian, J. Pedro Simas, Kenneth M. Kaye
Publikováno v:
PLoS Pathogens, Vol 20, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/9f847d6fa86f4b719971120e2dbb416b
Autor:
Ana Fraga, Andreia F. Mósca, Diana Moita, J. Pedro Simas, Helena Nunes-Cabaço, Miguel Prudêncio
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
Coronavirus disease 2019 (COVID-19) and malaria, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Plasmodium parasites, respectively, share geographical distribution in regions where the latter disease is endemic, leading to
Externí odkaz:
https://doaj.org/article/51a27339265c46fa940b8c23594741c1
Autor:
Zahra Hasan, Kiran Iqbal Masood, Shama Qaiser, Erum Khan, Areeba Hussain, Zara Ghous, Unab Khan, Maliha Yameen, Imran Hassan, Muhammad Imran Nasir, Muhammad Farrukh Qazi, Haris Ali Memon, Shiza Ali, Sadaf Baloch, Zulfiqar A. Bhutta, Marc Veldhoen, J. Pedro Simas, Syed Faisal Mahmood, Kulsoom Ghias, Rabia Hussain
Publikováno v:
Health Science Reports, Vol 6, Iss 9, Pp n/a-n/a (2023)
Abstract Background and Aims COVID‐19 vaccinations have reduced morbidity and mortality from the disease. Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have been associated with immune protection. Seroprevalenc
Externí odkaz:
https://doaj.org/article/565f488e64124230b6d07d32778da326
Autor:
Agnieszka Szymula, Gabriela Samayoa-Reyes, Sidney Ogolla, Bing Liu, Shijun Li, Athira George, Nicholas Van Sciver, Rosemary Rochford, J. Pedro Simas, Kenneth M. Kaye
Publikováno v:
Cell Reports, Vol 42, Iss 7, Pp 112767- (2023)
Summary: Kaposi’s sarcoma herpesvirus (KSHV) establishes lifelong infection and persists in latently infected B cells. Paradoxically, in vitro B cell infection is inefficient, and cells rapidly die, suggesting the absence of necessary factor(s). KS
Externí odkaz:
https://doaj.org/article/c1d1cd8cfd444ee9bb32c010a02070aa
Autor:
Syed Hani Abidi, Kehkashan Imtiaz, Akbar Kanji, Shama Qaiser, Erum Khan, Kiran Iqbal, Marc Veldhoen, Kulsoom Ghias, J. Pedro Simas, Zahra Hasan
Publikováno v:
PLoS ONE, Vol 16, Iss 12 (2021)
Background Individuals recovering from COVID-19 are known to have antibodies against the Spike and other structural proteins. Antibodies against Spike have been shown to display viral neutralization. However, not all antibodies against Spike have neu
Externí odkaz:
https://doaj.org/article/924933fbad854cef81b3675e1f728744
Autor:
Sharvan Sehrawat, Oktay Kirak, Paul-Albert Koenig, Marisa K. Isaacson, Sofia Marques, Gunes Bozkurt, J. Pedro Simas, Rudolph Jaenisch, Hidde L. Ploegh
Publikováno v:
Cell Reports, Vol 1, Iss 5, Pp 461-471 (2012)
To study the CD8+ T cell response against a mouse γ-herpes virus, we generated Kb-MHV-68-ORF8604–612RAG−/− CD8+ T cell receptor transnuclear (TN) mice as a source of virus-specific CD8+ T cells. Kb-ORF8-Tet+ CD8+ T cells, expanded in the cours
Externí odkaz:
https://doaj.org/article/50a45be07d2f423bbb0a62d340d861f1
Autor:
Bing Liu, Ángel L Álvarez, Qiming Sun, J. Pedro Simas, Min Tan, Franceline Juillard, Rute Chitas, Han Xue, Agnieszka Szymula, Colin E. McVey, Shijun Li, Tânia F Custódio, Kenneth M. Kaye, Jing Huang, She Chen
Publikováno v:
Nucleic Acids Research
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
'Nucleic Acids Research ', vol: 49, pages: 12895-12911 (2021)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
'Nucleic Acids Research ', vol: 49, pages: 12895-12911 (2021)
Mixed lineage leukemia 1 (MLL1) is a histone methyltransferase. Kaposi's sarcoma-associated herpesvirus (KSHV) is a leading cause of malignancy in AIDS. KSHV latently infects tumor cells and its genome is decorated with epigenetic marks. Here, we sho
Autor:
Zahra Hasan, Kiran Iqbal Masood, Shama Qaiser, Erum Khan, Areeba Hussain, Zara Ghous, Unab Khan, Maliha Yameen, Imran Hassan, Muhammad Imran Nasir, Muhammad Farrukh Qazi, Haris Ali Memon, Shiza Ali, Sadaf Baloch, Zulfiqar A. Bhutta, Marc Veldhoen, J. Pedro Simas, Syed Faisal Mahmood, Rabia Hussain, Kulsoom Ghias
Long-term solutions against SARS-CoV-2 infections require understanding of immune protection induced by different vaccine COVID-19 formulations. We investigated humoral and cellular immunity induced by Sinopharm (BBIBP-CorV) in a region of high SARS-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16aa2cf82cf9d8b68a9e6f9cc95cbbce
https://doi.org/10.1101/2022.11.30.518633
https://doi.org/10.1101/2022.11.30.518633
Autor:
Zahra Hasan, Kiran Iqbal Masood, Shama Qaiser, Erum Khan, Areeba Hussain, Zara Ghous, Unab Khan, Imran Hassan, Maliha Yameen, Haris Ali Memon, Shiza Ali, Sadaf Balouch, Muhammad Imran Nasir, Muhammad Farrukh Qazi, Marc Veldhoen, J Pedro Simas, Zulfiqar A Bhutta, Syed Faisal Mahmood, Rabia Hussain, Kulsoom Ghias
Introduction Sinopharm (BBIBP-CorV) inactivated virus vaccination for COVID-19 has been administered widely in Pakistan. We investigated the dynamics of BBIBP-CorV -induced antibody responses over a 24 week period in a region with a high seroprevalen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feb409f971332e9c2eee14b0503c1337
https://doi.org/10.21203/rs.3.rs-1763604/v1
https://doi.org/10.21203/rs.3.rs-1763604/v1